LOXO ONCOLOGY INC's ticker is LOXO and the CUSIP is 548862101.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2018 | $38,379,000 | -1.9% | 274,000 | +19.7% | 1.70% | +18.2% |
| Q3 2018 | $39,120,000 | -1.5% | 229,000 | 0.0% | 1.44% | -12.9% |
| Q2 2018 | $39,727,000 | +50.4% | 229,000 | 0.0% | 1.65% | +33.3% |
| Q1 2018 | $26,420,000 | +10.1% | 229,000 | -19.6% | 1.24% | -1.1% |
| Q4 2017 | $23,991,000 | -8.6% | 285,000 | 0.0% | 1.25% | -15.9% |
| Q3 2017 | $26,254,000 | -38.2% | 285,000 | -46.2% | 1.49% | -43.8% |
| Q2 2017 | $42,501,000 | +74.4% | 530,000 | -8.5% | 2.65% | +64.0% |
| Q1 2017 | $24,364,000 | +2.5% | 579,000 | -21.8% | 1.61% | +4.3% |
| Q4 2016 | $23,765,000 | +22.7% | 740,000 | 0.0% | 1.55% | +30.7% |
| Q3 2016 | $19,373,000 | +12.9% | 740,000 | 0.0% | 1.18% | +12.7% |
| Q2 2016 | $17,153,000 | -15.2% | 740,000 | 0.0% | 1.05% | -7.1% |
| Q1 2016 | $20,232,000 | +28.5% | 740,000 | +33.7% | 1.13% | +43.6% |
| Q4 2015 | $15,741,000 | +165.5% | 553,300 | +63.1% | 0.79% | +128.8% |
| Q3 2015 | $5,929,000 | +34.9% | 339,200 | +39.2% | 0.34% | +44.5% |
| Q2 2015 | $4,394,000 | +207.9% | 243,700 | +112.7% | 0.24% | +122.4% |
| Q1 2015 | $1,427,000 | – | 114,600 | – | 0.11% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|